Search
Florquinitau (18F)
go.drugbank.com/drugs/DB19215ApprovedFlorquinitau F 18 is a radioactive diagnostic drug used as a fluorine-18–labeled positron emission tomography (PET) tracer. It binds to aggregated tau protein, which in Alzheimer's disease forms the neurofibrillary tangles (NFTs) that ar...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesHydrastinine
go.drugbank.com/drugs/DB19359ExperimentalCategories: Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Enzyme InhibitorsFluroxene
go.drugbank.com/drugs/DB20681ExperimentalFluroxene is a small molecule drug. Fluroxene has a monoisotopic molecular weight of 126.03 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesTaltobulin
go.drugbank.com/drugs/DB20832ExperimentalTaltobulin is a small molecule drug. Taltobulin has a monoisotopic molecular weight of 473.33 Da.
Categories: P-glycoprotein substratesTabimorelin
go.drugbank.com/drugs/DB20892ExperimentalTabimorelin is a small molecule drug. The usage of the INN stem '-relin' in the name indicates that Tabimorelin is a pituitary hormone-release stimulating peptide. Tabimorelin has a monoisotopic molecular weight of 528.31 Da.
Categories: Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 InhibitorsDapitant
go.drugbank.com/drugs/DB20991ExperimentalThe usage of the INN stem '-pitant' in the name indicates that Dapitant is a neurokinin NK1 (substance P) receptor antagonist. Dapitant has a monoisotopic molecular weight of 561.29 Da.
Lapisteride
go.drugbank.com/drugs/DB21206ExperimentalLapisteride is a small molecule drug. The usage of the INN stem '-steride' in the name indicates that Lapisteride is a androgen/anabolic steroid. Lapisteride has a monoisotopic molecular weight of 464.3 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesMetacetamol
go.drugbank.com/drugs/DB21287ExperimentalMetacetamol is a small molecule drug. Metacetamol has a monoisotopic molecular weight of 151.06 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 InhibitorsNivasorexant
go.drugbank.com/drugs/DB21506ExperimentalNivasorexant is a small molecule drug. The usage of the INN stem '-orexant' in the name indicates that Nivasorexant is a orexin receptor antagonist. Nivasorexant has a monoisotopic molecular weight of 429.19 Da.
Categories: Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C9 InhibitorsAlpibectir
go.drugbank.com/drugs/DB21561InvestigationalAlpibectir is a small molecule drug. Alpibectir is under investigation in clinical trial NCT06748937 (A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide). Alpibectir has a monoisoto...
Categories: P-glycoprotein inhibitors, Cytochrome P-450 CYP3A Inhibitors